(a)<p>Biopsies were taken in the second part of duodenum.</p>(b)<p>IBD: Sulfasalazine, 5-aminosalicylic acid drug, Steroid; CF: ciproxin 500 mg (x2)/die (not provided for 2 months prior sampling).</p>(c)<p>PCDAI, Paediatric Crohn’s Disease Activity Index; PUCAI: Paediatric Ulcerative Colitis Activity Index; FEV1%, Forced Expiratory Volume (in percentage).</p
Inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)], are chronic re...
<p>Clinical characteristics of patients with Crohn's disease and ulcerative colitis.</p
<p>UC, ulcerative colitis; CD, Crohn’s Disease; 5ASA, 5-aminosalicylic acid; IFX, infliximab</p><p>A...
<p>5-ASA = 5-aminosalicylic acid preparations, Pred = prednisone, AZA = azathioprine, ABX = antibiot...
<p>Continuous variables are presented as median and range.</p><p><sup>1</sup>: CD: Crohn’s disease, ...
<p>Disease localization and disease behaviour for Crohn's disease and the disease extent in ulcerati...
*<p>Steroids_Resp-DepvsRefrac.</p><p>CD: Crohn's disease, UC: ulcerative colitis, IMS: immunosuppres...
INTRODUCTION: There is currently an increasing use of biological agents in the management of Crohn's...
OBJECTIVES: Predicting short-term relapses and long-term prognosis is of utmost importance in paedi...
<p>Baseline characteristics of the study population. IBD: inflammatory bowel disease.</p
<p>Abbreviations: ALB, albumin; CAI, clinical activity index; CD, Crohn's disease; CDAI, Crohn's dis...
p.64-68Background - Crohn’s disease is a chronic inflammatory disorder with diversity on its clinica...
<p>Demographic and clinical profile of the inflammatory bowel disease patients.</p
<p><sup>a</sup>Values are given as mean ± standard deviation</p><p><sup>b</sup> Crohn’s disease</p><...
Background:To describe the clinical characteristics of inflammatory bowel disease (IBD) at diagnosis...
Inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)], are chronic re...
<p>Clinical characteristics of patients with Crohn's disease and ulcerative colitis.</p
<p>UC, ulcerative colitis; CD, Crohn’s Disease; 5ASA, 5-aminosalicylic acid; IFX, infliximab</p><p>A...
<p>5-ASA = 5-aminosalicylic acid preparations, Pred = prednisone, AZA = azathioprine, ABX = antibiot...
<p>Continuous variables are presented as median and range.</p><p><sup>1</sup>: CD: Crohn’s disease, ...
<p>Disease localization and disease behaviour for Crohn's disease and the disease extent in ulcerati...
*<p>Steroids_Resp-DepvsRefrac.</p><p>CD: Crohn's disease, UC: ulcerative colitis, IMS: immunosuppres...
INTRODUCTION: There is currently an increasing use of biological agents in the management of Crohn's...
OBJECTIVES: Predicting short-term relapses and long-term prognosis is of utmost importance in paedi...
<p>Baseline characteristics of the study population. IBD: inflammatory bowel disease.</p
<p>Abbreviations: ALB, albumin; CAI, clinical activity index; CD, Crohn's disease; CDAI, Crohn's dis...
p.64-68Background - Crohn’s disease is a chronic inflammatory disorder with diversity on its clinica...
<p>Demographic and clinical profile of the inflammatory bowel disease patients.</p
<p><sup>a</sup>Values are given as mean ± standard deviation</p><p><sup>b</sup> Crohn’s disease</p><...
Background:To describe the clinical characteristics of inflammatory bowel disease (IBD) at diagnosis...
Inflammatory bowel diseases (IBD) [Crohn's disease (CD) and ulcerative colitis (UC)], are chronic re...
<p>Clinical characteristics of patients with Crohn's disease and ulcerative colitis.</p
<p>UC, ulcerative colitis; CD, Crohn’s Disease; 5ASA, 5-aminosalicylic acid; IFX, infliximab</p><p>A...